Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Hammerman

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 17, 2023
Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome AnalysisHilmi Alnsasra, Gal Tsaban, Adam Solomon, et al.
Frontiers in Pharmacology|August 21, 2023
Dapagliflozin versus empagliflozin in patients with chronic kidney diseaseHilmi Alnsasra, Gal Tsaban, Adam Solomon, et al.
Diagnostics (Basel, Switzerland)|September 13, 2025
Age-Based Oocyte Yield in Elective Oocyte Cryopreservation: A Retrospective Cohort StudyRonit Machtinger, Atalia Tuval, Ariel Hammerman, et al.
The Lancet. Infectious Diseases|April 16, 2023
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort studyRonen Arbel, Alon Peretz, Ruslan Sergienko, et al.
European Journal of Internal Medicine|June 15, 2016
Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort studyMartin H Ellis, Tsipora Neuman, Haim Bitterman, et al.
The Oncologist|June 9, 2017
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness AnalysisDaniel A Goldstein, Qiushi Chen, Turgay Ayer, et al.
The Oncologist|April 4, 2023
Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort StudyOded Icht, Avi Leader, Erez Batat, et al.
JAMA Dermatology|March 24, 2015
Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year StudyGuy Shalom, Devy Zisman, Haim Bitterman, et al.
Breast Cancer Research and Treatment|April 8, 2022
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysisAdi Pomerantz, Daliah Tsoref, Ahuva Grubstein, et al.
Frontiers in Oncology|August 9, 2021
Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy BiomarkersSameh Daher, Yaacov R Lawrence, Elizabeth Dudnik, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 17, 2023
Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome AnalysisHilmi Alnsasra, Gal Tsaban, Adam Solomon, et al.
Frontiers in Pharmacology|August 21, 2023
Dapagliflozin versus empagliflozin in patients with chronic kidney diseaseHilmi Alnsasra, Gal Tsaban, Adam Solomon, et al.
Diagnostics (Basel, Switzerland)|September 13, 2025
Age-Based Oocyte Yield in Elective Oocyte Cryopreservation: A Retrospective Cohort StudyRonit Machtinger, Atalia Tuval, Ariel Hammerman, et al.
The Lancet. Infectious Diseases|April 16, 2023
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort studyRonen Arbel, Alon Peretz, Ruslan Sergienko, et al.
European Journal of Internal Medicine|June 15, 2016
Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort studyMartin H Ellis, Tsipora Neuman, Haim Bitterman, et al.
The Oncologist|June 9, 2017
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness AnalysisDaniel A Goldstein, Qiushi Chen, Turgay Ayer, et al.
The Oncologist|April 4, 2023
Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort StudyOded Icht, Avi Leader, Erez Batat, et al.
JAMA Dermatology|March 24, 2015
Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year StudyGuy Shalom, Devy Zisman, Haim Bitterman, et al.
Breast Cancer Research and Treatment|April 8, 2022
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysisAdi Pomerantz, Daliah Tsoref, Ahuva Grubstein, et al.
Frontiers in Oncology|August 9, 2021
Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy BiomarkersSameh Daher, Yaacov R Lawrence, Elizabeth Dudnik, et al.
Pageof 6